# National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases is a Research Institute based in Bethesda, United States.

## Overview

- **Organization type:** Research Institute
- **Headquarters:** Bethesda, United States
- **Region:** North America
- **Address:** Bethesda, MD, United States
- **Founded:** 1948
- **Assets under management:** Undisclosed
- **Website:** niaid.nih.gov

## Regulatory record

- **Reports private funds:** No

## About

The National Institute of Allergy and Infectious Diseases (NIAID) is a component of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services. NIAID supports research on infectious and immune-mediated illnesses, including HIV/AIDS, tuberculosis, malaria, and autoimmune disorders. NIAID has made 127 investments, with its latest being in Moonlight Therapeutics on October 16, 2025, and has 22 portfolio exits, with EpiVax being its latest on April 02, 2026.

## Offices

- Hamilton, MT

## People

- Jeanne Marrazzo — Director

## Questions

### Who runs investment decisions at NIAID?

NIAID is a US federal agency, not an investment firm. Its budget is appropriated annually by Congress, and research funding decisions are made through peer-reviewed grant processes managed by scientific program officers. The director sets overall strategic priorities.

### How does NIAID source proprietary research and development opportunities?

NIAID sources research through investigator-initiated R01 grant applications, cooperative agreements with academic centers, and partnerships with pharmaceutical companies and non-profits. The institute also runs its own intramural laboratories, including the Vaccine Research Center, that initiate programs independent of external applicants.

### Does NIAID participate in fund commitments or only direct research funding?

NIAID does not make fund commitments. All funding is allocated through direct extramural grants (to universities and research hospitals), cooperative agreements, or intramural laboratory operations at its Bethesda and Hamilton, Montana campuses.

### How is NIAID related to BARDA and the Strategic National Stockpile?

NIAID conducts and funds early-stage and clinical research that can transition to advanced development by the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services. The Vaccine Research Center codeveloped the Moderna COVID-19 mRNA vaccine through a partnership with BARDA.

## Related profiles

- [Manifold Partners](https://altss.com/profile/manifold-partners)
- [DirectMed Imaging](https://altss.com/profile/directmed-imaging)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/national-institute-of-allergy-and-infectious-diseases

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology